Dr. Madsen is a radiation oncologist and the medical director of Seattle Cancer Care Alliance (SCCA) Peninsula.
All patients should be treated as VIPs with timely appointments, efficient care, tailored information and support, the best scientifically supported treatment options available and most importantly compassion.
Radiation oncology, stereotactic radiotherapy, palliative care, breast cancer, head and neck cancers, skin cancers, gynecological cancers
- Medical Director, SCCA Peninsula
- Assistant Clinical Professor of Radiation Oncology, University of Washington School of Medicine
- MD: Stanford University School of Medicine
- Residency: Radiation Oncology, Stanford University
Languages: English, Danish
- Attending Physician, Section of Radiation Oncology, Virginia Mason Medical Center — 1993-2008
- Attending Physician, Anchorage Radiation Oncology Center — 2008-2009
- Founder and Clinic Director, Peninsula Cancer Center — 2009-2019
I became interested in medicine as a high school student when I took biology and human biology from an enthusiastic and inspiring teacher. I pursued my interest in college and, naturally, headed into health care. I find the work to be meaningful and always challenging.
While an undergraduate at Stanford, I took a course entitled "The Biosocial Aspects of Cancer," an interdisciplinary course taught by a team of world-renowned cancer specialists and superb clinicians. I was hooked. Later in medical school, I rotated in the medical and radiation oncology departments and just felt it was my calling. The science and technology aspects of cancer are fascinating, while the delivery of care requires a truely multidisciplinary approach that is challenging and rewarding.
I am currently providing care in a community setting where I am able to give my patients access to large national clinical trials. In the past, I was the principal investigator on the groundbreaking early trial of stereotactic radiotherapy for prostate cancer. Stereotactic radiotherapy for prostate cancer has since become a widely accepted treatment option, allowing me to experience the satisfaction of my early research bearing fruit.
In my lifetime, I think cancer will become less prevalent, due to successful vaccines and other preventative technologies. Diagnostic work ups will become more accurate as a result of the improved imaging techniques and genetic profiling already starting to emerge. Finally, treatments will be more targeted and less toxic. I also think that patients and society will become more concerned about of quality-of-life issues and the financial cost of cancer care.
Outside of caring for patients, I enjoy outdoor adventures as well as gardening, cooking and reading good books.